Clinical Trial Update: A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 safety and pharmacokinetic study of CVX-045 in patients with advanced solid tumors; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• CVX-045

Snippet

Sponsor: Pfizer | Conditions: Advanced Solid Tumors, Neoplasms | Phase 1 | Status: COMPLETED